Working on CDMO for Macromolecular Target Drugs
“Full cycle biopharmaceutical technology platform, undertaking engineering cell construction to large-scale (15,000 liters) OEM”
Hualan Ankang Biotechnology Co., Ltd. was established in 2013 and has completed the construction of dozens of stable cell lines, 10+IND applications, and 100+batches of GMP production.
The company owns workshops of 5000L, 500L, and 200L complied with GMP standards. The commercial manufacturing scale ups to 40000L, with the area of 19000m2. There are two independent production lines with an annual capacity of 580000L, fully meet the needs of commercial production.
The senior leader team has worked in international pharmaceutical industry for 25 years on average, experienced in international technology transfer, oversea and domestic CDMO and promises to provide customers with a comprehensive solution of technical services, accelerate the process of product launching, and produce ultra-low-cost, high-quality biopharmaceuticals that meet the requirements of NMPA, FDA, EMA and other regulatory authorities in domestic and international markets with optimized processes and integrated information systems.
Full of vitality and wisdom, we are brave in innovation and forging ahead with enthusiasm and talent. Holding the ideas of honesty and efficiency, we keep trying to “dedicating for human health”.
Integrity management
Caring for life, human-oriented
Dedicating for human health
International competitiveness
Provide safe bio-pharmaceutical products
Unity, pioneering, dedication, endeavor
Quality safety guarantees reputation
Safety is the priority